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Abstract
We employed the Cre recombinase/loxP system to create a mouse line in which PKA activity can be inhibited in any cell-
type that expresses Cre recombinase. The mouse line carries a mutant Prkar1a allele encoding a glycine to aspartate
substitution at position 324 in the carboxy-terminal cAMP-binding domain (site B). This mutation produces a dominant
negative RIa regulatory subunit (RIaB) and leads to inhibition of PKA activity. Insertion of a loxP-flanked neomycin cassette
in the intron preceding the site B mutation prevents expression of the mutant RIaB allele until Cre-mediated excision of the
cassette occurs. Embryonic stem cells expressing RIaB demonstrated a reduction in PKA activity and inhibition of cAMP-
responsive gene expression. Mice expressing RIaB in hepatocytes exhibited reduced PKA activity, normal fasting induced
gene expression, and enhanced glucose disposal. Activation of the RIaB allele in vivo provides a novel system for the
analysis of PKA function in physiology.
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Introduction
The cyclic AMP-dependent protein kinase (PKA) holoenzyme
exists as an inactive heterotetrameric complex of two catalytic (C)
subunits that are bound and inhibited by two dimerized regulatory
(R) subunits [1]. Cooperative binding of two cAMP molecules to
each R subunit causes the release of active C subunit [2] and leads
to downstream cellular changes in the activity of transcription
factors, enzymes, ion channels, and many other cellular substrates
[3,4]. The mouse genome encodes four R subunit genes (RIa,
RIb, RIIa, RIIb) and two C subunit genes (Ca and Cb) [5].
Furthermore, both Ca and Cb genes have alternative splice
variants, thus adding to the diversity of PKA signaling pathways
[6,7]. Most tissues constitutively express the a subunits whereas the
expression patterns of the b subunits are more restricted. A major
obstacle in studies to delineate the role of PKA in specific
physiological pathways has been our inability to obtain cell-type
specific inhibition or activation of the kinase in vivo.
One approach to study the physiological role of PKA in vivo has
relied on molecular genetic techniques to disrupt specific PKA
subunit genes or overexpress mutant forms of PKA subunits. Each
PKA subunit gene has been individually disrupted in mice [8–14]
and despite the widespread expression patterns of R and C
isoforms, only the disruption of RIa results in embryonic lethality
[11]. Furthermore, in RIb-, RIIa-, and RIIb-null mice, the RIa
subunit has the ability to compensate for the loss of other R
subunits in several tissues and it has been suggested that RIa serves
as a physiological ‘‘buffer’’ to limit the activity of free C subunit
when it exists in excess of R subunit [15].
The R subunits have two cAMP binding sites (A and B) in the
carboxyl terminal domain of the protein and mutations that
disrupt cAMP binding to either site inhibit the ability of cAMP to
activate the mutant holoenzyme [16]. In the present study, we
used gene targeting to introduce a point mutation into exon 11 of
the endogenous RIa allele. This point mutation results in a Gly to
Asp substitution at amino acid 324 within the site B cAMP-
binding domain in RIa and is identical to the site B mutation first
characterized in S49 cells. This mutation prevents cAMP from
binding to site B and produces a dominant negative phenotype in
cell culture [17–20]. The introduction of a loxP-flanked neomycin
resistance (neo
r) cassette and polyadenylation signal into the intron
upstream of the site B mutation prevents expression of the mutant
RIa allele; however, in the presence of Cre recombinase, excision
of the floxed neo
r cassette permits expression of mutant RIa.W e
use this strategy to activate the dominant negative allele in
embryonic stem (ES) cells in culture and in hepatocytes in vivo and
report the effects on kinase activation, gene regulation, and
metabolic parameters.
Results
Analysis of the RIaB/Cre mutant phenotype in ES cells
A 6.6 kb 129svJ mouse RIa genomic fragment containing exons
9–11 was used to generate the RIaB targeting construct. Site-
directed mutagenesis was performed to introduce a single point
mutation into exon 11 encoding the B site cAMP-binding domain.
This mutation has been previously described to inhibit cAMP
binding to the B site in the RIa subunit, thereby generating a PKA
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insertion of a loxP-flanked neo
r cassette into the intron upstream of
the B site mutation effectively shuts off expression from the mutant
allele, termed RIaB (Figure. 1A). REK2 mouse embryonic stem
(ES) cells [8] (3 out of 324 analyzed) that had properly integrated
the RIaB construct by homologous recombination were identified
by Southern blot with a 39 probe that distinguishes the wild type
(WT) and floxed-neo
r mutant alleles (Figure 1B). The presence of
the B site mutation was confirmed by polymerase chain reaction
(PCR) and an Hph1 DNA restriction digest (Figure 1C).
To confirm the ability of the floxed-neo
r cassette to effectively
disrupt expression of the mutant RIa allele, RT-PCR analysis of
mRNA isolated from WT and RIaB ES clones was performed
(Figure 2A). Amplification of the WT RIa gene generates an RT-
PCR product of 140 bp that can be digested with either BstN1 (as
shown in Figure 2A) or Hph1 to give a 53 bp fragment that is
detected by Southern blot hybridization as described in Materials
and Methods. We detected less than 2% mutant mRNA (the
140 bp fragment that is resistant to BstN1) in correctly targeted ES
cell recombinants, indicating that the presence of the floxed-neo
r
cassette with tandem poly A addition signals effectively precludes
mRNA production from the mutant allele. ES cells containing this
‘‘silent’’ mutant allele are thus heterozygous at the RIa locus.
To determine whether the loss of a single RIa allele affected
PKA activity, we performed kinase assays on RIaB and WT ES
cells. No measurable changes were observed in kinase activity from
ES cells harboring the RIaB allele compared to WT ES cells,
suggesting that a single allele is sufficient to maintain wild type
levels of PKA activity in ES cells (Figure 2C, RIaB lane). To
determine if Cre-mediated excision of the floxed-neo
r cassette
would result in expression of the mutant RIa subunit, we
transfected a plasmid expression vector encoding Cre recombinase
(Cre) into the ES cells. After recombination, a single 56 base pair
fragment containing the 34 base pair loxP site and flanking
nucleotides should remain in the intron and this small insertion
was exploited to distinguish between WT (309 bp) and mutant
(365 bp) alleles. The transfection strategy resulted in efficient
removal of the floxed-neo
r cassette in approximately 15% of the
RIaB ES cell clones, generating a transcriptionally active mutant
RIa allele designated RIaB/Cre (Figure 2B). Since there is still
one WT allele present in RIaB/Cre ES cell clones, the expected
amount of total mutant mRNA should be 50%. We detected
Figure 1. Targeting construct to generate RIaB mice. A, The upper diagram shows a simplified restriction map of a 6.6 kb fragment of the RIa
genomic sequence encoding exons 9, 10 and 11 that was subcloned into Bluescript KS
+. The middle diagram is the targeted allele (RIaB), which
contains the B site mutation (G324D) in exon 11 (as indicated by an asterisk) and a loxP-neomycin resistance cassette inserted into a BglII site in intron
10. The bottom diagram is the Cre modified mutant RIa allele containing a single loxP site (RIaB/Cre). Restrictions sites: EcoRI, E; BglII, B; XhoI, X. B,A
Southern blot of EcoRV-digested genomic ES cell DNA using a 39 SphI/EcoRI genomic probe (as indicated by the black box). This strategy recognizes
6.6 kb fragment corresponding to the WT allele and a 7.5 kb fragment corresponding to the mutant RIa allele, RIaB. An asterisk indicates the correctly
targeted clone. C, Identification of the B site mutation (as indicated by the asterisk) was confirmed by an Hph1-mediated restriction digest of a 153 bp
PCR fragment generated with a primer set that amplifies within the site B cAMP domain of a WT (lane 1) and site B mutant plasmid vector (lane 2). In
WT cells, Hph1 digestion of the 153 bp PCR product yields two products (126 bp and 27 bp) (lanes 3, 4, 5), whereas Hph1 digestion of the 153 bp
amplicon from RIaB ES cells, which carry a single mutant allele and a single WT allele, results in three fragments: 153 bp (mutant), 126 bp (WT) and
27 bp (WT).
doi:10.1371/journal.pone.0018772.g001
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activated mutant RIa allele (Figure 2A, lane 3) indicating that
expression of mRNA from both the WT and mutant allele was the
same. The expression of the mutant protein in RIaB/Cre ES cells
resulted in a 60% reduction in both basal and cAMP-stimulated
kinase activity compared to unrecombined RIaB or WT ES cells
(Figure 2C). However, the lower PKA activity associated with the
expression of mutant RIa did not impair proliferation or survival
of these ES cell recombinants (data not shown).
Inducible CREB-dependent gene expression is
attenuated in RIaB expressing ES cells
Several studies have shown that the C subunit can translocate to
the nucleus and phosphorylate serine 133 on CREB, the
transcriptional activator of cAMP-responsive genes [21,22]. To
determine if reductions in PKA activity caused by expression of
RIaB could decrease CREB-dependent gene transcription, we
transfected a cAMP-Responsive Element (CRE)-luciferase report-
er construct into WT, RIaB, and RIaB/Cre ES cells. Basal
transcription of the CRE-luciferase reporter was similar in all ES
cells regardless of the state of the RIa alleles (Figure 2D).
Treatment of both WT and RIaB ES cells with the adenylyl
cyclase activator forskolin resulted in a three-fold induction in
CRE-luciferase activity (Figure 2D). In contrast, forskolin-induced
transcription was diminished by 90% in RIaB/Cre ES cells as
shown in (Figure 2D, last lane). The capacity of RIaB protein
(expressed from a single endogenous allele) to attenuate cAMP-
inducible gene transcription in ES cells supports its application in
vivo as a dominant inhibitor of PKA.
RIaB mice have wild type levels of PKA activity
The microinjection of correctly targeted RIaB ES cells into
C57BL/6 blastocysts produced male chimeras that were subse-
quently bred to C57BL/6 females to produce F1 animals
harboring a single RIaB allele and a wild type RIa allele. On a
mixed 129Sv/J and C57BL/6 background, RIaB mice are
healthy, fertile, and physically indistinguishable from WT
littermates. However, on a higher percentage C57BL/6 back-
ground, RIaB male mice are subfertile. This result is consistent
with our previous study of RIa heterozygous mice on a high
C57BL/6 background [23]. Because insertion of the floxed-neo
r
upstream of the mutated exon 11 is functionally equivalent to the
targeted disruption of the RIa gene, intercrossing RIaB mice to
produce homozygotes is predicted to result in early embryonic
lethality similar the original RIa-null animals [11]. As predicted,
no viable double mutant RIaB mice were born from the
Figure 2. Cre recombinase-mediated activation of the RIaB
allele in ES cells decreases PKA activity and forskolin-
stimulated CRE-luciferase reporter expression. A, Transfection
of ES cells with a Cre expression vector (pOG231) results in the
expression of mutant RNA transcripts. Levels of mutant transcripts were
determined by RT-PCR, restriction digestion, and Southern analysis as
described in Materials and Methods. The 53 bp fragment indicates WT
and the 140 bp fragment indicates mutant RIa transcripts. The small
upper band present in lane 1 (WT) is due to incomplete digestion with
BstN1, and was subtracted from lane 2 (RIaB) to determine the level of
mutant RNA in these cells (,2%). The level of mutant transcript in RIaB/
Cre ES cells is ,49%. B, Detection of Cre-mediated recombination
events in RIaB/Cre ES cells was determined by PCR using primers 1 and
2 (as shown in the figure) to amplify across the specified regions. Lane 1
is a WT control, Lane 2 is positive control for recombination. Lane 3
represents RIaB ES cells, which contain a single band due to presence of
single WT RIa allele (the PCR conditions did not allow amplification
through the floxed-neo
r cassette). Lane 4 represents RIaB/Cre ES cells,
which contain a recombined allele (356 bp) and WT allele (309 bp). C,
Kinase assay of basal and total activity in WT, RIaB, and RIaB/Cre ES
cells. All samples were done in triplicate in the absence (basal PKA
activity) or presence of 5 mM cAMP (total PKA activity) using Kemptide
as substrate. Kinase activity that was not PKA-specific was measured in
the presence of PKI and subtracted from basal and total values. Data
values are represented as mean 6 SEM. D, Representative CRE-
luciferase assay. WT, RIaB, and RIaB/Cre ES cell lines were transfected
with the CRE-dependent a168-luciferase reporter and then stimulated
with forskolin (10 uM) for 14 h before an assay for luciferase activity as
described in Materials and Methods. Transfections were done in
triplicate.
doi:10.1371/journal.pone.0018772.g002
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mice have normal levels of PKA activity in select tissues, kinase
assays were performed on a panel of tissues including heart,
kidney, brain, skeletal muscle, and pancreas. Tissues from RIaB
mice expressed PKA activity comparable to WT mice, suggesting
that one active RIa allele is sufficient to maintain PKA activity in
most situations (Figure 3A). However, these RIaB animals have
the same phenotypes that we have documented for RIa
heterozygotes; this includes male infertility when the animals are
on a C57BL/6 background and increased tumor susceptibility as
the animals age [23,24].
Liver-specific expression of the mutant R subunit reduces
PKA activity
To test whether the inhibitory mutant RIa allele could be
activated in vivo, we mated RIaB mice to transgenic mice
expressing Cre recombinase under the control of the albumin
promoter (Alb-cre). This promoter has been demonstrated to
restrict expression of Cre recombinase to liver hepatocytes [25].
Previous studies have shown that Alb-cre transgenic animals
obtain maximum recombination levels of floxed alleles at 5 to 8
weeks of age [26]. From birth through adulthood, RIaB/Alb-cre
animals appear to be healthy and physically indistinguishable
from aged-matched littermates. Genomic DNA analysis of brain,
heart, kidney, liver, pancreas and skeletal muscle from 8-week
old male mice revealed Cre-mediated recombination only in
liver DNA of RIaB/Alb-cre mice (Figure 3B). Kinase assays
revealed that the presence of the mutant RIa subunit in liver
extracts caused a significant reduction in both basal and cAMP-
stimulated PKA activities compared to WT and RIaB mice
(Figure 3C). Since the estimated percentage of cells expressing
albumin in liver is close to 60% [27], it follows that the actual
inhibition of PKA in hepatocytes may be greater than we
observe for whole liver. These results demonstrate that the
expression of a single mutant RIa allele is sufficient to produce a
dominant inhibition of PKA activity in vivo. Western analysis of
liver extracts from WT, RIaBa n dR I aB/Alb-Cre mice revealed
an increase in RIa and Ca protein levels in the RIaB/Alb-Cre
mice; in contrast, RIIa protein levels were similar in all three
genotypes (Figure 3D).
Effects of RIaB activation on liver gene expression
Because expression of the RIaB protein significantly inhibited
cAMP-mediated induction of a CRE-luciferase reporter con-
struct in ES cells, we investigated whether inhibition of liver
PKA in vivo would specifically block the induction of potential
CREB-dependent genes important for liver function. Two
CRE-containing genes, phosphoenolpyruvate carboxykinase
(PEPCK) and glucose-6-phosphatase (G6Pase), both of which
are induced in response to fasting, were investigated [28,29]. It
has also been reported that PKA-mediated phosphorylation of
CREB stimulates the expression of PGC-1a (peroxisome
proliferator-activated receptor-c coactivator 1a) and this tran-
scriptional coactivator strongly induces the expression of several
gluconeogenic enzymes, including PEPCK and G6Pase [30,31].
Surprisingly, liver-specific reductions in PKA had no significant
effect on the induction of PGC-1a, PEPCK or G6Pase during
fasting conditions, as shown in Figure 4. Following a 6 hr
refeeding period, PEPCK, G6Pase and PGC-1a transcripts all
returned to basal levels despite the expression of RIaB. As a
control the levels of Glut2 and GAPDH mRNA are shown and
they were not significantly changed by either nutritional state or
genotype. The mRNA levels for glucokinase (GCK) are
inhibited during fasting by a cAMP-dependent mechanism
and induced by insulin in fed animals [32]. However, GCK also
responded normally in both RIaBa n dR I aB/Alb-cre mice
compared with WT (Figure 4). Collectively, these data show
that despite liver-specific reductions in PKA activity, the
induction of genes essential for gluconeogenesis (PGC1a,
PEPCK, and G6Pase) and the repression of GCK remain
functionally intact.
Whole body parameters are normal in RIaB/Alb-cre mice
Between 6 to 12 weeks of age, no significant differences were
found in body weight and or liver weight of RIaB/Alb-cre mice
compared to RIaB or WT mice (Table 1). To investigate the
effects of a PKA deficiency in the regulation of blood glucose
homeostasis, individual mice were subjected to fasting and
refeeding conditions, and then assayed for plasma blood glucose
and insulin levels. All three genotypes had similar decreases in
plasma blood glucose and insulin after a 24 hr fasting period
(Table 1). After a 24 hr fast, refeeding for six hours produced
similar increases in plasma blood glucose and insulin. No
differences were observed between genotypes with respect to
plasma non-esterified fatty acids (NEFA) or triglycerides during
fasting or feeding conditions (Table 1).
Enhanced glucose disposal in RIaB/Alb-cre mice
Despite the apparently normal physiology of the RIaB/Alb-
cre mice during fasting and refeeding, we hypothesized that they
might respond differently when directly challenged by an
infusion of glucose. RIaB/Alb-cre mice were fasted for 24 hr
and then injected i.p. with 2 mg of glucose per gram of body
weight and blood glucose levels were measured at the indicated
time points. Basal glucose levels measured after the 24 hr fast
and before the glucose challenge did not reveal a difference
between WT, RIaB, and RIaB/Alb-Cre mice, although the
RIaB/Alb-Cre mice did show a trend of lower glucose levels that
did not reach statistical significance (Figure 5A). However, with
the glucose challenge, RIaB/Alb-cre mice exhibited a significant
improvement in total body glucose disposal compared to both
WT and RIaB mice at 15, 30, and 60 min time points
(Figure 5B). Although RIaB/Alb-cre mice demonstrated en-
hanced glucose disposal, their acute response to an insulin
challenge appeared normal (Figure 5C).
Removal of the other major regulatory subunit in liver
from RIaB/Alb-cre mice does not alter the enhanced
glucose disposal
Liver expresses both RIa and RIIa and the mutant RIaB
protein expressed after Alb-cre induced recombination must
compete for C subunits with both WT RIa and RIIa.I n
Figure 3 we demonstrated that expression of the RIaB allele was
only able to inhibit PKA activity by about 60%. We reasoned that
genetic deletion of the other liver PKA regulatory subunit (RIIa)
on the RIaB/Alb-cre background might allow us to achieve
greater inhibition of PKA activity. As shown in Figure 6A, kinase
activity in whole liver homogenates was reduced by about 80% in
RIIa KO:RIaB/Alb-cre mice and some fraction of the remaining
20% of PKA activity is likely to come from the non-hepatocyte cell
types of the liver. Glucose tolerance tests on the RIIa KO:RIaB/
Alb-cre mice demonstrated a greatly enhanced glucose disposal,
exceeding that observed in RIaB/Alb-cre mice on a WT
background (Figure 6B). A trend toward enhanced glucose
disposal was also observed in RIaB mice in the absence of Cre
recombinase (Figure 5B, 6B), suggesting the mice heterozygous for
RIa exhibit improved glucose disposal.
A Dominant Negative PKA Mutation in Mice
PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18772Figure 3. Cre-mediated activation of RIaB allele specifically in the liver decreases PKA activity in vivo. A, Kinase assay on tissue
homogenates from WT and RIaB mice measured in the absence (basal) or presence (total) of 5 mM cAMP using kemptide as the substrate. Non-PKA
specific activity was measured in the presence of PKI and subtracted from basal and total values. Data values are represented as mean 6 SEM; n=3
animals per group. B, Representative PCR analysis of genomic DNA of brain (B), heart (H), kidney (K), liver (L) pancreas (P) and skeletal muscle (SM)
were examined for Cre-mediated recombination of the RIaB allele in WT, RIaB and RIaB/Alb-cre mice. A 309 bp fragment indicates WT RIa, whereas a
365 bp fragment indicates the recombined mutant RIa allele, which was restricted to the liver. C, Kinase assay on liver homogenates from WT, RIaB,
and RIaB/Alb-cre measured in the absence (basal) or presence (total) of 5 mM cAMP using Kemptide as the substrate. Non-PKA specific activity was
measured in the presence of PKI and subtracted from basal and total values. Data values are represented as mean 6 SEM; n=3 animals per group. D,
Representative western analysis and quantitation of pixel density on film exposures from WT, RIaB/Alb-Cre and RIaB mouse liver extracts. Data values
in bar graph are represented as mean 6 SEM. n=4 replicates.
doi:10.1371/journal.pone.0018772.g003
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PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18772Figure 4. Liver-specific PKA inhibition does not alter fasting-regulated gene expression. mRNA levels of enzymes required for
gluconeogenesis in the 24 hr fasted state (Fast) or after being fasted for 24 hr then allowed access to food for 6 hr (Fed) in WT, RIaB, and RIaB/Alb-cre
mice. Levels of each mRNA were measured by quantitative real time PCR as described in Materials and Methods. Data are expressed relative to the
results of a fasted WT control animal. Each value represents the mean 6 SEM; n=3 animals per group. No significant differences were found in gene
induction. PGC-1a (peroxisome proliferator-activated receptor-c coactivator 1a), PEPCK (phosphoenolpyruvate carboxykinase), G6Pase (glucose-6-
phosphatase), GCK (glucokinase), GAPDH (glyceraldehyde 3-phosphate dehydrogenase), and GLUT2 (glucose transporter type 2).
doi:10.1371/journal.pone.0018772.g004
Table 1. Plasma glucose, insulin, and metabolite concentrations in 24 hr fasted or 24 hr fasted and 6 hr refed animals.
Genotype Body weight(g)
Liver wt (%
body wt)
Blood Glucose
(mg/dl) Insulin (ng/ml)
Non-esterified fatty
acids (mEq/L)
Triglycerides
(mg/dl)
Fast Refed Fast Refed Fast Refed Fast Refed
WT 27.36.8 4.56.1 73631 0 3 63. 6 3 6.04 2.06.3 2.26.1 .386.02 57642 8 62
RIaB 27.36.8 4.86.4 72631 0 9 63. 5 6 6.07 1.86.3 2.46.1 .446.03 55662 9 63
RIaB/Alb-cre 27.76.7 4.86.2 66641 0 5 62. 7 6 6.15 1.686.5 2.26.2 .476.04 56642 8 62
Age-matched male mice 12 to 18 weeks old were bled after a 24 hr fast and 6 hr refeeding. Blood for all measurements was obtained from the hindlimb saphenous
vein. Each value represents the mean 6 SEM. No significant differences were found in any of these parameters. For liver weight determination, n=5 animals per
genotype and for all other measurements, n=7–16 animals per genotype.
doi:10.1371/journal.pone.0018772.t001
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cell type
Our results demonstrate the ability of the floxed RIaB mouse
model to effectively inhibit PKA activity in vivo in specific cell
types. We have demonstrated the utility of this strategy in
collaboration with other laboratories to determine the role of PKA
in development of the enteric nervous system [33] and in class-
switch recombination in the immune system [34]. Additionally, we
have crossed the RIaB mouse to several Cre Driver mouse lines
and have observed significant alterations in the physiology of
target tissues (Table 2). The ability to inhibit PKA activity in vivo in
a cell-type-specific manner represents a significant addition to the
technologies available for asking questions about the role of PKA
in different biological processes.
Discussion
We have utilized the Cre/loxP recombination system to devise
a novel strategy to produce lesions in the PKA signaling pathway
in vivo. The ES cells and mice that we have created carry a
silenced RIa mutant allele (RIaB) that, when activated by Cre
recombinase, expresses an RIa protein that is defective in cAMP
binding. Holoenzymes composed of this mutant RIa subunit
require nearly 100 fold higher concentrations of cAMP for half
maximal activation compared to native holoenzymes [16,20] We
have activated this silenced allele in ES cells and demonstrate that
expression of the RIaB protein affects PKA-dependent kinase
activity as well as cAMP-induced gene expression. Activation of
the mutant RIa allele in hepatocytes using Alb-cre transgenic mice
results in a substantial decrease in PKA activity only in the liver,
demonstrating that the RIaB mice can be used to elicit a
dominant negative PKA effect in a cell-specific manner in vivo.
Although kinase activity is clearly reduced when the RIaB allele
is activated, we do observe an increase in RIa and Ca protein
levels, suggesting that PKAI holoenzyme is stabilized in the
inactive state; this is consistent with previous work from our
laboratory demonstrating that RIa and Ca proteins are more
stable when incorporated into holoenzyme [15] and also with our
Figure 5. RIaB/Alb-cre mice exhibit increases in glucose disposal. A, Blood glucose levels were determined in 24 hr fasted WT, RIaB, and RIaB/
Alb-cre mice. n=10. B, Glucose tolerance test was performed in 24 hr fasted WT, RIaB, and RIaB/Alb-cre mice injected i.p. with 2 mg of glucose per
gram of body weight. Blood glucose levels were determined at the indicated time points. Over the first 60 min, the glucose disposal of RIaB/Alb-cre
was significantly enhanced compared to RIaB alone (p,.001). n=7. C, WT, RIaB, and RIaB/Alb-cre mice were injected with 0.75 mU of insulin per
kilogram of body weight at time 0 and blood glucose levels were determined at the indicated time points. Values are presented as means 6 SEM.
n=10.
doi:10.1371/journal.pone.0018772.g005
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the RIaB mouse (Table 2).
One important criterion that must be established before using
the Cre/loxP system in mice is that the RIaB allele is effectively
silenced prior to Cre recombination. We have demonstrated that
insertion of a floxed-neo
r gene into intron 10 upstream of the site B
mutation in exon 11 conditionally regulates expression of the
mutant RIa allele. As demonstrated by RT-PCR experiments,
when the floxed-neo
r cassette is present, the silent RIaB allele
effectively renders ES cells and mice heterozygous at the RIa
locus. The floxed-neo
r gene employed in this study contains splice
donor/acceptor sites from the SV40 small T antigen and tandem
poly A addition signals and is inserted in the same orientation as
the gene. It is likely that the poly A addition sequence causes early
termination of the mutant transcript.
OnceactivatedbyCre-mediatedexcisionofthefloxed-neo
rcassette,
ES cells and hepatocytes expressing the RIaBp r o t e i ne x h i b i t
significant reductions in basal and cAMP-stimulated PKA activity.
However, this approach does not completely eliminate PKA activity
as can be seen for RIaBe x p r e s s i n gE Sc e l l sw h e r ea l lo ft h ec e l l sh a v e
activated the RIaBa l l e l ea n dy e t4 0 %o ft h eP K Aa c t i v i t yr e m a i n s .
We have previously shown that overexpression of a dominant
negative RIa protein, R(AB), in cell culture completely inhibits PKA
activity [19]. This difference may be due in part to the fact that the
dominant-negative R(AB) subunit is completely resistant to cAMP
activation whereas the single RIaBs i t em u t a t i o n( G 3 2 4 D )c r e a t e di n
our mice can still respond to high levels of cAMP (Ka=4.7mM
cAMP)[20]. Probably a more significant difference is that stable
R(AB) transformants in cell culture contain many copies of the R(AB)
construct driven by robust promoters that produce a large excess of
mutant protein. In our ES and mouse model systems, a weaker
mutant (RIaB) is being transcribed from only a single allele under the
control of the endogenous RIa promoter and this may not be
adequate to sequester all of the available C subunits.
The cAMP-dependent regulation of gene expression is thought
to occur in part through the phosphorylation of CREB/ATF
transcription factors bound to DNA regulatory sequences known
as CREs located in the promoter of many genes [35].
Transcriptional activation is initiated by phosphorylation of serine
133 in CREB by the C subunit of PKA and studies have shown
that translocation of C into the nucleus stimulates transcription of
CRE-containing genes [21,36,37]. It has been demonstrated that
expression of R(AB) in various cell lines blocks cAMP-responsive
gene induction of CRE-containing promoters [22,38]. In this
paper we show that attenuation of PKA activity by RIaB
activation in ES cells also blocked the ability of cAMP to induce
transcription from a CRE-luciferase reporter construct.
The ability of RIaB to inhibit CREB-dependent gene
expression in ES cells prompted us to examine the regulation of
genes within the gluconeogenic pathway in the liver of RIaB
expressing mice. Several of the genes essential for gluconeogenesis
have been identified as CREB-regulated (including PEPCK and
G6Pase) and are thought to be induced by PKA activation [29,39].
CREB has also been shown to induce the transcriptional
coactivator PGC-1a in the liver [40], which regulates the
expression of several gluconeogenic enzymes including PEPCK
and G6Pase [30]. We were surprised to find that PGC-1a,
PEPCK, G6Pase, and GCK were all expressed and regulated
normally by nutritional state in livers expressing the dominant
negative RIaB allele. One explanation for these results is that the
PKA inhibition by RIaB is not complete and sufficient kinase
activity remains to support gene regulation.
An alternative view, which we favor, is that the complex
nutritional/hormonal regulation of these genes in a physiological
setting facilitates compensation for the partial loss of PKA activity
and tends to maintain the normal levels of gene expression. In
addition to CREB itself, the gluconeogenic program is modulated
by CREB-regulated transcription coactivator 2 (CRTC2), which is
phosphorylated by Salt Inducible Kinase 2 (SIK2) and excluded
from the nucleus by binding to 14-3-3 proteins. Fasting-dependent
increases in glucagon result in a dephosphorylation of CRTC2,
which then allows CRTC2 to enter the nucleus and promote
transcription of CREB target genes by interacting with the b-ZIP
domain of CREB [41]. Insulin inhibits CRTC2-dependent
induction of gluconeogenesis via Akt-dependent phosphorylation
andactivation ofSIK2,resultinginphosphorylation ofCRTC2and
ubiquitin-dependent degradation of CRTC2 in the proteosome
[42]. Insulin also potently inhibits gluconeogenesis through the
activation of PI3 kinase, resulting in Akt phosphorylation of FOX01
Figure 6. RIaB/Alb-cre mice and RIaB mice on the RIIa KO
background exhibit increases in glucose disposal. A, Representa-
tive kinase assay of basal and total kinase activity in WT, RIaB, RIaB/Alb-
Cre,RIIaKO, RIaB:RIIaKO, and RIaB/Alb-Cre:RIIaKO liver. All samples were
done in triplicate in the absence(basal) or presence (total) of 5 mM cAMP
using Kemptide as substrate. Kinase activity that was not PKA-specific
was measured in the presence of PKI and subtracted from basal and total
values. Data values are represented as mean 6 SEM. At least three mice
from each genotype were used for the kinase assay. B, Glucose tolerance
tests on 24 hr fasted WT,RIaB andRIaB/Alb-Cre mice all crossed onto the
RIIa KO background are shown. Two mg of glucose per gram of body
weight was injected i.p. and blood glucose levels were determined at the
indicated time points. Values are presented as means 6 SEM. n=5.
Glucose levels in RIaB/Alb-cre animals were significantly reduced
compared to WT and RIaB during the first 30 min. P,0.01.
doi:10.1371/journal.pone.0018772.g006
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absolute requirement for PKA activity in gluconeogenic gene
expression is also supported by the finding that disruption of the
CREB-CBP interaction in liver does not attenuate expression of
gluconeogenic genes such as PEPCK, G6Pase and PGC-1a [41].
The observation that RIaB/Alb-cre mice exhibit improved
glucose disposal was unanticipated, since these animals properly
adjust blood glucose and insulin levels during periods of fasting
and refeeding. Based on our gene expression data, the improve-
ment in glucose disposal in these mice cannot be directly linked to
impairments in gluconeogenic gene expression. In the liver, there
is a balance between insulin and cAMP signaling pathways and
dysregulation of this equilibrium has been suggested to be one of
the underlying mechanisms involved in the development of type 2
diabetes [45]. Perhaps the downregulation of PKA in the liver has
shifted the balance between these two pathways, favoring insulin-
like tone and improving the clearance of glucose from the blood
stream. Further studies are required to elucidate the precise role of
liver-specific PKA inhibition on whole body glucose disposal.
Because of the many roles associated with PKA function in liver, it
also remains to be determined if reductions in PKA activity alters
other aspects of liver physiology such as regeneration [46] or
xenobiotic transformation [47].
Our strategy renders mice heterozygous at the RIa locus, and
expression from a single wild-type RIa allele appears to be
adequate to maintain wild type PKA activity levels in most tissues.
However, we have recently discovered that RIa heterozygosity
alone produces phenotypes that include sperm abnormalities and
subsequent infertility [23] as well as late onset development of soft
tissue sarcomas, hemangiosarcomas, chondrosarcomas and hepa-
tocellular carcinomas [24]. Experiments to understand the
consequences of RIa heterozygosity on male fertility have been
conducted in RIa heterozygous mice on a C57BL/6 genetic
background. Isolation of mature sperm from these mice reveals
profound morphological abnormalities with frequent broken heads
and ruptured tails. This phenotype is reversed by mating RIa
heterozygotes onto the Ca heterozygote background, demonstrat-
ing that sperm defects are due to unregulated C subunit activity at
some point in development [23]. Interestingly, somatic mutations
that result in a similar loss of function have been described in the
human RIa locus (PRKAR1a) in patients with Carney complex, a
familial multiple neoplasia syndrome characterized by cardiac and
extracardiac myxomas, schwannomas, endocrine and gonadal
tumors [48–50]. The possibility of these and other phenotypes
associated with the unactivated RIaB mouse line needs to be
considered and controlled for when interpreting physiological
studies with these animals.
As a genetic tool, the RIaB mice can serve as a starting point to
study the role of cAMP/PKA signaling in vivo. Using a very similar
Cre/lox strategy we have previously reported the development of
a mouse line that expresses a constitutively active Ca subunit
(CaR) in response to activation by Cre recombinase [51]. Using
these two mouse lines (RIaB and CaR), PKA activity can be
modulated in either direction in vivo in any cell type for which a
Cre Driver mouse exists. Evidence from crosses with other Cre-
expressing mice has revealed the utility of RIaB in elucidating the
effects of PKA in physiology. When RIaB is expressed specifically
in neural crest progenitor cells using the PLP-cre and Hox11L1-cre,
RIaB expression leads to craniofacial dysmorphism and severe
enteric dysfunction [33]. Expression of RIaB in B cells disrupts the
PKA dependent regulation of class switch recombination [34].
Expression of RIaB in the collecting duct cells of the kidney
disrupts aquaporin-2 expression and function, causing diabetes
insipidus (M. Gilbert, L. Yang, and G.S. McKnight, unpublished
observations). Due to the broad expression pattern of RIa, this
approach to selectively inhibit PKA activity using the Cre/loxP
system should prove useful for the study of PKA signaling in many
different cellular and physiological responses in vivo.
Materials and Methods
Ethics statement
All mouse procedures were approved under protocol 2022-01,
titled ‘‘Regulation of cAMP-Dependent Protein Kinase Genes, by
our Institutional Animal Care and Use Committee (IACUC) at the
University of Washington, which operates under approval number
A3464-01 from the Association for Assessment and Accreditation
of Laboratory Animal Care (AAALAC).
RIaB targeting vector
To generate the site B mutation (G324D) in the RIa protein, a
6.6 kb genomic EcoRI fragment containing exons 9, 10, and 11 of
Table 2. Phenotypes Observed by Activating the RIaB Allele with Various Cre Driver Mouse Lines.
Cre Driver Tissue/cell types undergoing recombination Observed Phenotype Reference
Albumin-Cre liver hepatocytes enhanced glucose disposal with glucose
challenge
this manuscript
AP2-Cre BAT, partial heart and WAT edema-related complications B.S. Willis and G.S. McKnight, unpublished
observations
Cd21-Cre Mature B cells impaired class-switch recombination (CSR) Vuong et al.(2009)
Darpp32-Cre striatum short limbs; lean; hypophagic; impaired
rotarod performance
L.Yang and G.S. McKnight, unpublished
observations
Hox11L1-Cre neural crest-derived enteric neurons lethal intestinal pseudo-obstruction Howe et al.(2006)
PLP-Cre neural crest-derived tissues, CNS, PNS and ENS lethal intestinal pseudo-obstruction Howe et al.(2006)
ROSA26-Cre ubiquitous embryonic lethality B.S. Willis and G.S. McKnight, unpublished
observations
Sf1-Cre VMH hypothalamus; testis; ovary; pituitary; adrenal females appear normal; males appear normal
with smaller testis and seminal vesicles
L. Yang and G.S. McKnight, unpublished
observations
Sim1-Cre PVN hypothalamus; kidney collecting duct nephrogenic diabetes insipidus M. Gilbert, L. Yang and G.S. McKnight,
unpublished observations
doi:10.1371/journal.pone.0018772.t002
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genomic fragment was subcloned into a pUC18 vector and site-
directed mutagenesis (QuikChange
TM Stratagene) was performed
to introduce a single G to A mutation in exon 11 using the
oligonucleotide sequences 59-TCTTTTCCAGATGAATTGCC-
CTGCTGA-39and 59-AGCCAGGGCAATTTCATCTGGAAA-
AGAGA-39.AloxP flanked neomycin selection cassette containing
the SV40 promoter, the neomycin phosphotransferase gene, and
two SV40 polyadenylation sequences was inserted into a unique
BglII restriction site between exons 10 and 11. 120 mg of the
targeting vector was linearized at an unique Not1 site and
electroporated into 1.2610
7 mouse REK2 ES cells [8] using a
Progenitor
TM II PG200 electroporator at 240 mV, 500 mF
(Hoefer Scientific Instruments) and then selected in G418
(280 mg/ml) and 1000 U/ml leukemia inhibiting factor (LIF) for
approximately 7 days before colonies were picked. DNA isolated
from ES clones was digested with EcoRV and Southern blot
analysis using Church and Gilbert hybridization buffer (250 mM
sodium phosphate pH 7.2, 1 mM EDTA, 1% BSA, 7% SDS at
68uC) was performed to identify clones with the correct integration
of the targeting vector using a 225 bp SphI/EcoRIR I a genomic
fragment located 39 to the targeting vector. Identification of the
site B mutation was confirmed by PCR analysis using the oligo
sequences 59-CGCTTGAGGATGTCTGAGCAC-39and 59-
GTGATAGTCGTTACTGTCTC-39 (94uC for 1 min followed
by cycles of 94uC for 30 sec, 62uC for 30 sec and 72uC for 1 min
for 29 cycles). Amplified PCR products were then digested with
Hph1 (New England Biolabs) and analyzed on 14% acrylamide
gels. The 153 bp DNA fragment corresponds to the site B mutant
RIa allele and the 126 bp and 27 bp DNA fragments correspond
to the WT RIa allele. Positively identified clones were microin-
jected into C57BL/6 blastocysts that were then implanted into
pseudopregnant females. Male chimeric offspring were bred with
C57BL/6 females and RIaB agouti offspring were identified by
Southern blot and PCR analyses as described above.
Transient transfection of ES cells with Cre recombinase
2610
7 RIaB ES clones were electroporated with 50 mgo f
pOG231, an expression vector encoding Cre recombinase driven
by a CMV promoter (a generous gift from Stephen O’Gorman,
Salk Institute, San Diego, CA) and seeded at ,100 cells/cm
2 on
PMEF feeder layer in 10 cm dish. Individual ES colonies were
picked and allowed to expand.
Detection of Mutant RIa transcript
Expression of the mutant RIa mRNA was confirmed by
Reverse Transcription-PCR analysis using the following oligonu-
cleotides: 59-CGAAAGAGGAAGATGTATGAA-39 (exon 8) and
59-GGACAGGGACACGAAGCTGTT-39 (exon 11) (94uC for
1 min followed by cycles of 94uC for 30 sec, 62uC for 30 sec and
72uC for 1 min for 29 cycles) which amplifies a 140 bp fragment
from both WT and mutant RIa cDNAs. PCR products were
digested with BstN1, which overlaps the site of the point mutation
and only cuts the WT product. The digested fragment was
separated on a 2% agarose gel, and subjected to Southern blot
analysis using a P
32-end labeled oligonucleotide (59-AGC-
CAGGGCAATTTCATCTGGAAAAGAGA-39). The blot was
exposed to X-Omat AR film for 3 hr and bands were quantified
using NIH Image. The 53 bp band corresponds to WT RIa
mRNA and the 140 bp band corresponds to RIaB mRNA.
Recombination PCR analysis across loxP site
A PCR-based screening method using the oligonucleotide
sequences 59-TGATGGGATTGAATGTAGGC-39 and 59-TTA-
GAACAAGCTTCACTGTAC-39 (94uC for 1 min followed by
cycles of 94uC for 30 sec, 62uC for 30 sec and 72uC for 1 min for
29 cycles) was used to determine the presence of the single loxP site
that remains after Cre-mediated recombination of the floxed
neomycin resistance cassette within the RIaB allele. The 309 bp
fragment corresponds to the WT RIa allele and the 365 bp
fragment corresponds to the recombined mutant RIa allele.
Transient transfection of ES cells with a CREB-dependent
luciferase reporter
REK2 ES clones [8] were seeded at a density of 1.8610
5 cells/
well in a 24 well plate before being transiently transfected using
calcium phosphate precipitation with 2.5 ng of a CRE reporter
gene (a168-luciferase), 50 ng of RSV b-galactosidase as an
internal control for transfection efficiency and carrier plasmid
pBluescript KS
+ (Stratagene) to bring the total amount of DNA to
250 ng/well. Precipitates remained on the ES clones for 20 to
24 hr at 37uC in a 3% CO2 incubator. To induce expression of
a168-luciferase, ES cells were incubated in DMEM supplemented
with 2.5% fetal bovine serum 6 10 mM forskolin for 14 hr in 5%
CO2. After forskolin treatment, ES cells were washed once in ice
cold phosphate buffered saline, lysed, and harvested for reporter
analysis as described previously [52]. Transfections were per-
formed in triplicate and luciferase activity was normalized to RSV
b-galactosidase activity for each sample.
Generation of RIaB/Alb-cre mice
Hybrid (50% C57BL/6 and 50% 129SvJ) RIaB heterozygous
mice were backcrossed 3 or more generations with C57BL/6 mice
to produce RIaB mice on a .93% C57BL/6 genetic background.
Albumin-cre (Alb-cre) transgenic mice were purchased from The
Jackson Laboratory, Bar Harbor, ME. Because RIaB males on a
high C57Bl/6 background are partially infertile, female RIaB mice
werecrossed to male Alb-cre transgenic miceto generate RIaB/Alb-
cre mice. Only male mice were used in these experiments. All mice
were maintained on a 12 hr light and 12 hr dark cycle with normal
mouse chow and water in an SPF facility.
Kinase assays
Protein extracts from ES cells, liver or tissues from ad libitum fed
8- to 10- week old male mice were prepared in ice-cold
homogenization buffer (20 mM Tris, pH 7.5, 250 mM sucrose,
0.1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 10 mM
dithiothreitol, 1 mg/ml leupeptin, 3 mg/ml aprotinin, 40 mg/ml
soybean trypsin inhibitor, 0.5 mM 4-(2-aminoethyl)benzenesulfo-
nyl fluoride) using a dounce homogenizer followed by brief
sonication (Branson Sonifier 250). Protein extracts were snap-
frozen in liquid nitrogen and stored at 280uC. Protein extracts
were thawed on ice and Bradford assays (BioRad) were performed
to determine protein concentration of each extract. Kinase assays
were performed in triplicate using the PKA substrate peptide
Kemptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly) in the presence or
absence of 5 mM cAMP [20]. Non-specific PKA activity was
measured in the presence of 4 mg/ml protein kinase inhibitor
(PKI) peptide and subtracted.
Western analysis
Western analysis, including description of the polyclonal
antibodies to RIa,C a, and RIIa, has been described [15].
Westerns were analyzed using the Image J software available by
ftp at zippy.nimh.nih.gov/or http://rsb.info.nih.gov/nih-imageJ;
developed by Wayne Rasband, National Institutes of Health,
Bethesda, MD.
A Dominant Negative PKA Mutation in Mice
PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e18772Plasma blood glucose, insulin, and metabolite
measurements
8 to 12 week old male mice were fasted for 24 hr or fasted for
24 hr followed by free access to chow for 6 hr. Blood from the
from hind limb saphenous vein was collected and blood glucose
levels were immediately measured using the One Touch II glucose
meter (LifeScan, Milpitas, CA). Serum insulin levels were
determined using a mouse insulin ELISA kit (Mercodia,
Metuchen, NJ). Nonesterified fatty acids were determined using
a diagnostic reagent kit (Wako Chemical USA, Richmond, VA)
and triglycerides were determined using a trinder kit (Sigma
Diagnostics, St Louis, MO).
Intraperitoneal glucose tolerance test
10 to 16 week old male mice were injected intraperitoneally
with 2.0 mg glucose per gram of body weight using a 20% (w/v)
glucose solution (in 0.9% NaCl solution). Blood samples were
collected from the hind limb saphenous vein at 215, 0, 15, 30, 60
and 120 min after injection and glucose levels were immediately
measured.
Real-time QRT-PCR
One step real time PCR was performed using the Mx3000P and
Brilliant QRT-PCR reagents (Stratagene, Cedar Creek, TX).
Total RNA was extracted from frozen mouse livers (14 to 20 week
old male mice) using Trizol reagent (LifeTechnologies, Inc.)
according to the manufacturer’s protocol and stored at 280uCi n
0.1 X SET (0.1% SDS, .5 mM EDTA, 1 mM Tris, pH 7.6). To
prepare RNA for qRT-PCR, samples were precipitated in 100%
ethanol, washed twice with 70% ethanol, then resuspended in
autoclaved double-distilled water. Relative levels of PGC-1a,
PEPCK, GLUT2, GCK, GAPDH, and G6Pase were determined
using TaqMan probe and primer sets designed for each gene, and
relative amounts of mRNA were determined based on a standard
curve using Stratagene Mx3000P software.
Statistical analyses
All data are presented as the mean 6 standard error of the
mean. Statistical significance was determined by one-way
ANOVA and repeated measures ANOVA was used on the
glucose tolerance tests followed by Tukey’s Multiple Comparison
Test. A p-value of less than 0.05 was considered statistically
significant. Prism
TM was used to plot data and determine statistical
significance.
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